Models
ZYDUS LIFESCIENCES LTDZYDUSLIFEPharmaceuticals & Biotechnology
854per share · Base Model Note
Revenue growth, the horizon and scenarios are yours to change. Every other input is part of the Trader plan; saving, sharing a saved link and the live-formula workbook are part of the Institutional plan.
Scenario
Value per share, your model854implied FY26 P/E 19.0× · EV/EBITDA 12.1×
Against CMP ₹1,119.1023.7%close of 2026-09-10
Growth the CMP implies28.7%revenue, a year for 5 years, on your other inputs
Value after FY3183%share of enterprise value in the terminal
This figure is the arithmetic of your inputs and nothing else. MarketPing publishes no fair value, target or rating; the model is yours.

Where the methods land · ₹ per share · the dashed line is the CMP

DCF, rate ±1 · growth ±1your model across the sensitivity grid
6191,324
52-week rangetraded range, a fact not a value
8361,205

From enterprise to equity · ₹ crore

PV of FY27FY31 free cash flow16,624
PV of terminal value79,519
Enterprise value96,142
less net debt(10,914)
less non-controlling interest0
add non-operating investments0
Equity value85,228
÷ 99.80 crore shares854
83% of the value sits after FY31. Usual when return on capital sits near the cost of capital; the 5 explicit years carry little of it.

Free cash flow, filed and modelled · ₹ '000 crore

-202468FY21: ₹2,439 croreFY21FY22: ₹876 croreFY22FY23: ₹1,658 croreFY23FY24: ₹2,321 croreFY24FY25: ₹5,064 croreFY25FY26: ₹(1,277) croreFY26FY27: ₹2,098 croreFY27FY28: ₹3,036 croreFY28FY29: ₹4,232 croreFY29FY30: ₹5,748 croreFY30FY31: ₹7,657 croreFY31
Filed, cash from operations − capexModelled free cash flow to firm

Sensitivity · ₹ per share

Down Across
WACCterminal growth4.0%4.5%5.0%5.5%6.0%
10.00%8879671,0621,1791,324
10.50%8058719481,0421,156
11.00%7347898549311,022
11.50%672720774838913
12.00%619659706760822
The outlined cell is your model. Green figures sit above the CMP of ₹1,119.10; n/a marks a terminal growth at or above the discount rate. Steps: WACC and terminal growth ±0.5 point, growth ±2, margin ±1.

Distribution of outcomes · 4,000 draws · growth, margin and the discount rate vary together

P10637P50844P901,098
10th · 50th · 90th percentile, ₹ per share637 · 844 · 1,098
Draws below the CMP91%
Rank correlation with ebitda margin+0.73
Rank correlation with discount rate0.52
Rank correlation with revenue growth+0.35
Each driver is drawn from a PERT distribution between the lowest and highest value across your scenarios (or ±50% growth, ±20% margin when there is one scenario), with the discount rate ±1.5 points. Seeded, so the same inputs give the same picture.

Projected cash flow to the firm · ₹ crore

History Forward
₹ croreFY23FY24FY25FY26FY27FY28FY29FY30FY31
Revenue17,23719,54723,24227,14831,76437,16343,48150,87359,521
growth %12.913.418.916.817.017.017.017.017.0
EBITDA3,2565,3706,8397,9599,30710,88912,74014,90617,440
margin %18.927.529.429.329.329.329.329.329.3
less depreciation(723)(764)(916)(1,408)(1,652)(1,932)(2,261)(2,645)(3,095)
EBIT2,5334,6065,9236,5517,6558,95610,47912,26014,345
less tax on EBIT(1,579)(1,845)(2,158)(2,525)(2,955)(3,457)
NOPAT4,9725,8106,7987,9549,30610,888
add depreciation7237649161,4081,6521,9322,2612,6453,095
less capex(1,031)(907)(1,713)(3,394)(3,970)(4,064)(4,074)(3,971)(3,714)
less working-capital build(1,394)(1,631)(1,908)(2,232)(2,612)
Free cash flow to firm1,6582,3215,0642,0983,0364,2325,7487,657
Discount factor0.9490.8550.7700.6940.625
Present value1,9912,5963,2603,9894,787
History columns are the filed years (free cash flow there is cash from operations − capex, as filed); the base year and everything to its right come from the engine. Forward is the explicit horizon of the model itself: 3, 5 or 10 years, then flat.

The three statements, projected · ₹ crore · debt held at 11,770, dividends at 22% of profit

₹ croreFY26FY27FY28FY29FY30FY31
Income statement
EBIT6,5517,6558,95610,47912,26014,345
Interest at 5.9% on debt(694)(694)(694)(694)(694)
Profit before tax6,9618,2629,78511,56613,650
Profit after tax5,0405,2836,2717,4268,77910,361
Dividends(1,106)(1,162)(1,380)(1,634)(1,931)(2,279)
Balance sheet, year end
Cash8551,2632,3934,4647,75412,604
Working capital8,1979,59011,22113,12915,36117,973
Net block and other assets43,35545,67447,80549,61850,94351,562
Debt11,77011,77011,77011,77011,77011,770
Equity29,58233,70338,59444,38751,23459,315
Balance check0(0)(0)00(0)
Cash flow
From operations5,5416,5737,7809,19210,844
Investing (capex)(3,970)(4,064)(4,074)(3,971)(3,714)
Financing (dividends)(1,162)(1,380)(1,634)(1,931)(2,279)
Net change in cash4081,1292,0723,2904,850
Free cash flow to equity1,5712,5093,7055,2217,130
Other liabilities are held at their FY26 level, so the check tests only what the model moves: cash, working capital, net block and other assets, debt and equity. A non-zero check would mean the three statements no longer tie.

Scenarios side by side · ₹ per share

ScenarioTemplateGrowthMarginRateTerminal₹ / sharevs CMP
Base · editingDCF17%29.3%11.00%5%854(23.7)%
A scenario is a full set of inputs under a name. Keep Base as the filed history carried forward; add Bull and Bear by saving the current inputs under those names and moving the two or three assumptions you actually hold a view on. The distribution above draws each driver between the lowest and highest value across your scenarios, so three scenarios give it a real range; with one scenario it falls back to fixed bands.